BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 30427879)

  • 1. Development and validation of quality of life instruments for chronic diseases-Chronic gastritis version 2 (QLICD-CG V2.0).
    Quan P; Yu L; Yang Z; Lei P; Wan C; Chen Y
    PLoS One; 2018; 13(11):e0206280. PubMed ID: 30427879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Chronic Gastritis Scale Under the System of Quality of Life Instruments for Chronic Diseases QLICD-CG Based on Classical Test Theory and Generalizability Theory.
    Wan C; Chen Y; Gao L; Zhang Q; Li W; Quan P
    J Clin Gastroenterol; 2022 Feb; 56(2):e137-e144. PubMed ID: 33852446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the osteoporosis scale among the system of quality of life instruments for chronic diseases QLICD-OS (V2.0).
    Liu Q; Li L; Ma W; Yang Z; Zhao R; Liu C; Wan C
    BMC Geriatr; 2024 May; 24(1):407. PubMed ID: 38714958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of the psoriasis scale among the system of quality of life instruments for chronic diseases QLICD-PS (V2.0).
    Liu Q; Feng L; Wan C; Tan J; Yu J; Wang L
    Health Qual Life Outcomes; 2022 Apr; 20(1):68. PubMed ID: 35459208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing minimal clinically important differences for the Quality of Life Instrument of Chronic Gastritis QLICD-CG(V2.0) based on distribution-based methods.
    Wu X; Chen Y; Wan C; Yu L; Lei P; Sun X
    BMC Gastroenterol; 2023 May; 23(1):149. PubMed ID: 37173655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of the systemic lupus erythematous scale amongst the system of quality of life instruments for chronic diseases QLICD-SLE (V2.0).
    Liu Y; Zhang J; Xue H; Chen M; Xie T; Wan C
    Health Qual Life Outcomes; 2023 Nov; 21(1):128. PubMed ID: 38017437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of the pulmonary tuberculosis scale of the system of Quality of Life Instruments for Chronic Diseases (QLICD-PT).
    Sun Y; Yang Z; Wan C; Xu C; Chen L; Xu L; Zhang X; Yan F
    Health Qual Life Outcomes; 2018 Jul; 16(1):137. PubMed ID: 29996931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of the rheumatoid arthritis scale among the system of quality of life instruments for chronic diseases QLICD-RA (V2.0).
    Yang Z; Bai G; Ding H; Chen M; Xie T; Wan C
    Sci Rep; 2024 Apr; 14(1):8954. PubMed ID: 38637566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and assessment of the Quality of Life Instruments for Chronic Diseases-Gout (QLICD-GO) (V2.0).
    Liu Q; Liu X; Zhang P; Xie X; Wan C; Wang X; Pan H
    Clin Rheumatol; 2023 Feb; 42(2):501-509. PubMed ID: 36414865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a disease-specific quality of life measure QLICD-HY (V2.0) for patients with hypertension.
    Liu Y; Chang Y; Wan D; Li W; Xu C; Wan C
    Sci Rep; 2023 Aug; 13(1):12935. PubMed ID: 37558743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the psychometrics properties of a French quality of life questionnaire among a cohort of renal transplant recipients less than one year.
    Beauger D; Fruit D; Villeneuve C; Laroche ML; Jouve E; Rousseau A; Boyer L; Gentile S
    Qual Life Res; 2016 Sep; 25(9):2347-59. PubMed ID: 27016945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of the coronary heart disease scale under the system of quality of life instruments for chronic diseases QLICD-CHD: combinations of classical test theory and Generalizability Theory.
    Wan C; Li H; Fan X; Yang R; Pan J; Chen W; Zhao R
    Health Qual Life Outcomes; 2014 Jun; 12():82. PubMed ID: 24894812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of the general module of the system of quality of life instruments for chronic diseases and its comparison with SF-36.
    Wan C; Tu X; Messing S; Li X; Yang Z; Zhao X; Gao L; Yang Y; Pan J; Zhou Z
    J Pain Symptom Manage; 2011 Jul; 42(1):93-104. PubMed ID: 21530153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of the Coronary Heart Disease Scale Among the System of Quality of Life Instruments for Chronic Diseases QLICD-CHD (V2.0) Based on Classical Test Theory and Generalizability Theory.
    Qiao L; Ding S; Ma W; Xu C; Zhang X; Liu Y; Wan C
    Int J Gen Med; 2024; 17():1975-1989. PubMed ID: 38736668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypertension scale of the system of Quality of Life Instruments for Chronic Diseases, QLICD-HY: a development and validation study.
    Wan C; Jiang R; Tu XM; Tang W; Pan J; Yang R; Li X; Yang Z; Zhang X
    Int J Nurs Stud; 2012 Apr; 49(4):465-80. PubMed ID: 22189098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of the irritable bowel syndrome scale under the system of quality of life instruments for chronic diseases QLICD-IBS: combinations of classical test theory and generalizability theory.
    Lei P; Lei G; Tian J; Zhou Z; Zhao M; Wan C
    Int J Colorectal Dis; 2014 Oct; 29(10):1245-55. PubMed ID: 25080147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic heart failure health-related quality of life questionnaire (CHFQOLQ-20): development and psychometric properties.
    Khajavi A; Moshki M; Minaee S; Vakilian F; Montazeri A; Hashemizadeh H
    BMC Cardiovasc Disord; 2023 Mar; 23(1):165. PubMed ID: 36991337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychometric properties of the Chinese version of the WHOQOL-HIV BREF to assess quality of life among people living with HIV/AIDS: a cross-sectional study.
    Zhu Y; Liu J; Qu B
    BMJ Open; 2017 Aug; 7(8):e016382. PubMed ID: 28827253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the peptic ulcer scale under the system of quality of life instruments for chronic diseases based on classical test theory and generalizability theory.
    Wan C; Chen Y; Gao L; Zhang Q; Quan P; Sun X
    BMC Gastroenterol; 2020 Dec; 20(1):422. PubMed ID: 33317456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory.
    Wu J; Hu L; Zhang G; Liang Q; Meng Q; Wan C
    Qual Life Res; 2016 Aug; 25(8):2087-100. PubMed ID: 26928910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.